Home Consortium Limited (ASX:HMC) acquired portfolio of 8 private oncology assets from Genesis Care Pty Ltd for approximately AUD 110 million on July 12, 2021. The acquisition price reflects a weighted average passing yield of approximately 4.5%. In a related transaction, there is an establishment of joint venture with operator Acurio Health Group to acquire and develop a 5-hectare integrated private hospital anchored health precinct in Camden. The acquisitions will be funded from cash and undrawn debt commitments. HomeCo’s existing senior debt credit approved commitments from lenders have sufficient capacity to fund the acquisitions. GenesisCare will continue to operate each centre. Completion of the acquisitions is subject to customary regulatory approvals and 3 of the 8 properties are subject to other third-party consents. Home Consortium Limited (ASX:HMC) completed the acquisition of portfolio of 8 private oncology assets from Genesis Care Pty Ltd on July 12, 2021.